Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Irmgard
Irmgard Görisch, Leonding AT
| Patent application number | Description | Published |
|---|---|---|
| 20100198185 | MULTI-CHAMBER BAG FOR USE WITH ENTERAL NUTRITION - The container according to the invention for use in enteral nutrition is characterized in that the container is a multi-chamber bag with at least two chambers separated from one another, wherein at least one chamber contains an enteral nutritive solution with a first energy content and at least one chamber contains a fluid for covering the fluid requirement with an energy content which is less than the energy content of the enteral nutritive solution. Since, with the multi-chamber bag according to the invention, both the enteral nutritive solution and the fluid also required for covering the fluid requirement are made available directly, the application in the case of enteral nutrition is simplified. | 08-05-2010 |
Irmgard Immig, Habsburg CH
| Patent application number | Description | Published |
|---|---|---|
| 20090324571 | USE OF BACTERIAL AMYLASES IN FEED FOR BOVINE ANIMALS - The invention relates to the use of at least one bacterial amylase in feed for ruminant animals of the subfamily Bovinae in particular for improving milk yield, apparent digestibility of the diet fed, feedstuff dry matter disappearance, weight gain, and/or Feed Conversion Ratio (FCR). Examples of bovine animals are dairy cows and beef cattle. The invention also relates to the use of such amylases in feed and feed additives such as premix, concentrates and total mixed ration (TMR). The amylase may be used in combination with cellulase for improving milk yield and/or back fat thickness. Preferred amylases are derived from | 12-31-2009 |
| 20110189349 | Fat soluble vitamin fed supplements and processes for delivering same - A process is disclosed for delivering a stable, fat soluble vitamin to a feed composition. The process includes dissolving a fat soluble vitamin in a solvent to form a vitamin-enriched solvent and combining the vitamin-enriched feeds; processes for supplementing the diet of a feed animal with a fat soluble vitamin, processes for extending the shelf life of an animal product, and processes for making stable vitamin-enriched supplements for feed compositions are also provided. | 08-04-2011 |
Irmgard Irminger-Finger, Geneva CH
| Patent application number | Description | Published |
|---|---|---|
| 20100016228 | TRUNCATED BARD1 PROTEIN, AND ITS DIAGNOSTIC AND THERAPEUTIC USES - The invention concerns a novel polypeptide derived from the cleavage of the BARD1 protein, a nucleic acid encoding for said polypeptide, and their diagnostic and therapeutic uses, in particular for treating tumors. | 01-21-2010 |
| 20100130590 | DELETION BEARING BARD1 ISOFORMS AND USE THEREOF - The present invention relates to new protein isoforms, use thereof, methods of preparation thereof, methods of detection thereof, antibodies thereof, combination of antibodies thereof, use of these antibodies and combinations thereof and use of antagonists of those isoforms for the treatment of gynaecological cancers. | 05-27-2010 |
Irmgard Merfort, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100144647 | Dual Acting Prodrugs - The present invention relates to a prodrug which comprises at least two different pharmaceutically and/or diagnostically active compounds independently bound by cleavable linkers and a protein-binding moiety which is capable of binding to carrier a molecule. | 06-10-2010 |
Irmgard Penzinger, Deutschlandsberg AT
| Patent application number | Description | Published |
|---|---|---|
| 20120098386 | Ceramic Material, Method for Producing said Ceramic Material and Component Comprising said Ceramic Material - The invention relates to a ceramic material of the formula [(Bi | 04-26-2012 |
Irmgard Schmidt, Solingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090120555 | Novel amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme - The invention relates to a novel amylolytic enzyme extracted from the microorganism | 05-14-2009 |
Irmgard Schwarte-Waldhoff, Mettmann DE
| Patent application number | Description | Published |
|---|---|---|
| 20110147218 | SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT - The invention relates to a method for the diagnosis and risk stratification of a tumor or cancer of the gastrointestinal tract, particularly colon tumor or colon cancer, wherein a determination is made on at least one patient using the novel soluble cadherin 17 biomarker—a proteolytic cleavage product of cadherin 17 having SEQ ID No. 1 or SEQ ID No. 2—or partial peptides and fragments thereof. | 06-23-2011 |
Irmgard Sinning, Bammental DE
| Patent application number | Description | Published |
|---|---|---|
| 20110118439 | Three-Dimensional Structure Of The Amyloid Precursor Protein Intracellular Domain (AICD) In Complex With Human FE65-PTB2 - The present invention relates to a three-dimensional structure of the intracellular domain (AICD) of human amyloid precursor protein (APP695) in complex with human Fe65-PTB2 (i.e. a protein-complex comprising the intracellular domain (AICD) of human amyloid precursor protein (APP695) and the human Fe65-PTB2), as well as to methods and uses of said three-dimensional structure for identifying ligands which modify the interaction between the AICD and the Fe65-PTB2. Moreover, the present invention relates to pharmaceutical compositions which contain one or more of such identified ligands for the prevention or treatment of neurodegenerative disorders. | 05-19-2011 |
Irmgard Tegeder, Frankfurt Am Main DE
| Patent application number | Description | Published |
|---|---|---|
| 20100144776 | USE OF SNPS FOR THE DIAGNOSIS OF A PAIN PROTECTIVE HAPLOTYPE IN THE GTP CYCLOHYDROLASE 1 GENE (GCH1) - The present invention relates to an in vitro method for diagnosing a genetic predisposition or susceptibility for pain in a mammal which comprises detecting of at least one particular single nucleotide polymorphism (SNP) in a sample obtained from said mammal in the genomic locus-derived nucleic acid or fragment thereof of the locus GCH1. | 06-10-2010 |
Irmgard Tegeder, Frankfurt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090162421 | DRUGS AS WELL AS THEIR PRODUCTION AND USE IN THE TREATMENT OF PAIN-ASSOCIATED NEUROPATHIES - The present invention relates to the use of tarenflurbil and/or a pharmaceutically tolerable salt or derivative thereof in enantiomerically-pure and/or essentially enantiomerically-pure form or a form that is enriched with respect to flurbiprofen racemate and/or a racemate of said salt or derivative, for the production of a drug for the treatment of pain-associated neuropathy, pain-associated neuropathy that is simultaneously accompanied by states of nociceptive pain, peripheral and/or predominantly peripheral neuropathic pain or central and/or predominantly central neuropathic pain. | 06-25-2009 |
| 20100261657 | Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains - The invention relates to the use of a granulin or a granulin-like compound for producing a pharmaceutical composition for the therapy or prophylaxis of chronic pain, in particular for neuropathic pain. | 10-14-2010 |
| 20110105405 | METHOD FOR ALLEVIATING PAIN USING PROTEIN ASSOCIATED WITH MYC AND RELATED COMPOUNDS, AND ASSAYS FOR IDENTIFYING SUCH COMPOUNDS - Use of PAM or functional fragments or derivatives thereof for the preparation of pharmaceutical compounds. | 05-05-2011 |
| 20110200994 | Method for Diagnosing a Genetic Predisposition for Vascular Disease - The invention relates to a method for diagnosing a genetic predisposition for a vascular disease, in particular for a coronary artery disease (CAD). According to the invention, the method has the following steps: Providing a sample containing a nucleic acid derived from the gene GCH1; and determining the presence or absence of a nucleotide polymorphism (SNP) of the gene GCH1 in the nucleic acid, wherein the SNP is selected from the group consisting of rs8007267 G>A, rs3783641 A>T, and rs10483639 C>G, wherein the presence of at least one of said SNPs indicates a genetic predisposition for a vascular disease. | 08-18-2011 |
| 20110207753 | METHODS FOR TREATING PAIN - The present invention features methods and compositions for preventing, reducing, or treating a traumatic, metabolic or toxic peripheral nerve lesion or pain including, for example, neuropathic pain, inflammatory and nociceptive pain by administering to a mammal in need thereof a compound that reduces the expression or activity of BH4. According to this invention, this reduction may be achieved by reducing the enzyme activity of any of the BH4 synthetic enzymes, such as GTP cyclohydrolase (GTPCH), sepiapterin reductase (SPR), or dihydropteridine reductase (DHPR); by antagonizing the cofactor function of BH4 on BH4-dependent enzymes; or by blocking BH4 binding to membrane bound receptors. The compounds of the invention may be administered alone or in combination with a second therapeutic agent. | 08-25-2011 |
Irmgard Westenberger, Mainz DE
| Patent application number | Description | Published |
|---|---|---|
| 20110111203 | SUBSTRATE WITH A SOL-GEL LAYER AND METHOD FOR PRODUCING A COMPOSITE MATERIAL - A substrate with a sol-gel layer and to a method for producing a composite material wherein a barrier layer is placed between the sol-gel layer and the substrate are provided. | 05-12-2011 |